1-21814686-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001013693.3(LDLRAD2):c.374C>T(p.Pro125Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000119 in 1,573,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001013693.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLRAD2 | NM_001013693.3 | c.374C>T | p.Pro125Leu | missense_variant | 2/5 | ENST00000344642.7 | NP_001013715.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDLRAD2 | ENST00000344642.7 | c.374C>T | p.Pro125Leu | missense_variant | 2/5 | 2 | NM_001013693.3 | ENSP00000340988.2 | ||
LDLRAD2 | ENST00000543870.1 | c.374C>T | p.Pro125Leu | missense_variant | 2/6 | 1 | ENSP00000444097.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000136 AC: 23AN: 169026Hom.: 0 AF XY: 0.000129 AC XY: 12AN XY: 93342
GnomAD4 exome AF: 0.000117 AC: 166AN: 1421252Hom.: 0 Cov.: 33 AF XY: 0.000119 AC XY: 84AN XY: 704084
GnomAD4 genome AF: 0.000138 AC: 21AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2023 | The c.374C>T (p.P125L) alteration is located in exon 2 (coding exon 2) of the LDLRAD2 gene. This alteration results from a C to T substitution at nucleotide position 374, causing the proline (P) at amino acid position 125 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at